Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
about
Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insultsMechanisms of action of CHF3381 in the forebrainThe chemical biology of clinically tolerated NMDA receptor antagonistsERK activation causes epilepsy by stimulating NMDA receptor activityInverse relationship between seizure expression and extrasynaptic NMDAR function following chronic NMDAR inhibition.The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivativesPharmacological interventions for stroke: failures and future.Recent developments in the pharmacological treatment of Parkinson's disease.Effect of memantine on lithium chloride induced head twitches in ratsStapling mimics noncovalent interactions of γ-carboxyglutamates in conantokins, peptidic antagonists of N-methyl-D-aspartic acid receptorsDual Therapeutic Effects of C-10068, a Dextromethorphan Derivative, Against Post-Traumatic Nonconvulsive Seizures and Neuroinflammation in a Rat Model of Penetrating Ballistic-Like Brain Injury.Synaptic and extrasynaptic plasticity in glutamatergic circuits involving dentate granule cells following chronic N-methyl-D-aspartate receptor inhibition.Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors.On the hypes and falls in neuroprotection: targeting the NMDA receptor.Current concepts in Alzheimer's disease: a multidisciplinary review.Dextromethorphan/quinidine sulfate for pseudobulbar affect.The role of glutamate and its receptors in multiple sclerosis.Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II.Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.Whole-cell patch-clamp analysis of recombinant NMDA receptor pharmacology using brief glutamate applications.Synthesis and pharmacological evaluation of (2-oxaadamant-1-yl)amines.GluN2D-Containing N-methyl-d-Aspartate Receptors Mediate Synaptic Transmission in Hippocampal Interneurons and Regulate Interneuron Activity.BQ-869, a novel NMDA receptor antagonist, protects against excitotoxicity and attenuates cerebral ischemic injury in stroke.The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control.A placebo double-blind pilot study of dextromethorphan for problematic behaviors in children with autism.Stereocontrolled synthesis and pharmacological evaluation of azetidine-2,3-dicarboxylic acids at NMDA receptorsEffects of ERK1/2 kinases inactivation on the nigrostriatal system of Krushinsky-Molodkina rats genetically prone to audiogenic seizures.Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate.N-methyl-D-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity.Spreading depression: imaging and blockade in the rat neocortical brain slice.Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers.Blocking the anoxic depolarization protects without functional compromise following simulated stroke in cortical brain slices.Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism.Ketamine alters behavior and decreases BDNF levels in the rat brain as a function of time after drug administration.Expression of genes involved in excitatory neurotransmission in anoxic crucian carp (Carassius carassius) brain.Endothelin-1-induced cerebral ischemia: effects of ketanserin and MK-801 on limb placing in rats.Hypoxia associated NMDA receptor 2 subunit composition: developmental comparison between the hypoxia-tolerant subterranean mole-rat, Spalax, and the hypoxia-sensitive rat.A structurally derived model of subunit-dependent NMDA receptor functionNMDA receptor-mediated neuroprotective effect of the Scutellaria baicalensis Georgi extract on the excitotoxic neuronal cell death in primary rat cortical cell cultures
P2860
Q24558984-26794187-544B-44FD-BFF7-CCE0151967D3Q24672441-34F14CE4-C0F9-46A5-8642-D1881BC9A2CCQ28248958-0F21AA08-E536-4892-B177-421877F0FD00Q30480774-C05AE994-7FCB-41F1-B94A-78760E7B2071Q34015816-65489FAA-D6DC-4819-8EFF-27B85B220A87Q34329204-032D5661-B926-4679-998C-AEBE8C0F1C7AQ34628650-423184F7-72FF-45B3-8ABE-2381857C93B0Q35185761-6227133C-9094-4DC5-B1A8-78F2FDF07EFFQ35365448-7E84D705-48CF-49C1-BE1C-3A964991180BQ36017011-ECA209E4-B82D-4314-96E2-77A7E0F20A86Q36123009-8D64F062-C94D-4BD3-B2DE-B37F7F634763Q36700706-62486AE3-C802-4FA9-9818-D8E69B819FD8Q36923095-75BF142A-0E9E-4404-9BC0-932D255A38C3Q36958209-E33C2535-4140-43C0-91FA-3471F08CEF43Q37360292-F60249B7-648C-4062-82AE-DEEE9D0A0973Q37366440-1D3DBCD7-29F5-44FC-B5AF-48F403353293Q38196367-0E8DDE3C-66BA-4814-A8DD-D1084EDB235FQ38342072-F2AC04D8-4756-4A7A-8551-3BBD65BF2BD8Q38632327-C4560642-76BC-4D90-BE48-720BF5BA8217Q38975453-FC0F53E3-4823-45F5-8621-64FB1583B14DQ39140111-6E7C7CA9-3AE6-48B7-85D4-AF96954261D2Q39393906-CEFCA8A6-FE0B-4F48-A2A7-0C6BDD392C14Q39617247-4F39E654-22E4-49BC-9E5C-45E195C9DD45Q39904357-BABDAB17-8333-4904-A74A-C85E93DD99F0Q40259304-C0907EDD-4906-4347-9F7C-83EBECCC893AQ42164772-446C298D-5373-4518-B945-DCBB15FF9294Q42512829-0C63567D-C327-49F0-8547-D9720B19A215Q42872711-EBFB9651-A68D-4112-B305-608DB62AFFA4Q42932168-0991F593-949C-4EC0-8FAC-C7BBC073FC8DQ44211149-F7633F7C-656D-4F5A-A31C-800F37F03AC8Q45040972-71013277-70A3-4D7A-8A7B-0E7A96EA40E1Q45084911-BB713B21-F7B0-4C8F-A2D6-A16BD4BD3512Q45300396-B7F99A92-7C27-48F3-ABFE-F2C1271E02B1Q45903198-CDA251E4-5691-429B-96A6-51B1EFED68A9Q46507493-13005569-FF38-4C54-9763-AB773F45A6F3Q48095034-6DC3DA4A-73B3-40A1-83D7-85D7CDC1A93EQ48519460-E54BF9AD-DBA2-49F7-B2D2-F40757FA8203Q58805055-4128963E-8F60-41B0-B8C4-27950723F336Q59100304-87F02688-71CB-4454-B985-CBF7168CF8AF
P2860
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
@ast
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
@en
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
@nl
type
label
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
@ast
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
@en
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
@nl
prefLabel
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
@ast
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
@en
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
@nl
P356
P1433
P1476
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
@en
P2093
P304
P356
10.2174/1389450013348335
P577
2001-09-01T00:00:00Z